Complete Pathological Response to Durvalumab in MSI-H Intrahepatic Cholangiocarcinoma Complicated by Drug-induced Sarcoid-like Reaction: A Case Report
Archives of Case Reports: Open Access · 20.07.2026 · 03 (02) · 01-05
DOI: 10.33140/acroa.03.02.02 ↗Kurz gefasst
Fallbericht in der Zeitschrift Archives of Case Reports: Open Access, online erschienen am 20.07.2026. Verfasst von Priyanka Barad und 4 weiteren Autor:innen.
Abstract (Originalsprache)
We present a rare case of complete pathological response in a patient with microsatellite instability-high cholangiocarcinoma treated with durvalumab, complicated by a drug-induced sarcoid-like reaction. This report highlights the profound efficacy of immune checkpoint inhibitors in microsatellite instability-high tumors, even in rare malignancies such as cholangiocarcinoma, while also illustrating the potential for complex immune-related adverse events, such as sarcoid-like reaction.
Zitieren
APA
Barad, P., Samji, N. S., Raja, F., Akce, M., & Malla, M. (2026). Complete Pathological Response to Durvalumab in MSI-H Intrahepatic Cholangiocarcinoma Complicated by Drug-induced Sarcoid-like Reaction: A Case Report. Archives of Case Reports: Open Access, 03(02), 01-05. https://doi.org/10.33140/acroa.03.02.02
Vancouver
Barad P, Samji NS, Raja F, Akce M, Malla M. Complete Pathological Response to Durvalumab in MSI-H Intrahepatic Cholangiocarcinoma Complicated by Drug-induced Sarcoid-like Reaction: A Case Report. Archives of Case Reports: Open Access. 2026;03(02):01-05. doi:10.33140/acroa.03.02.02
BibTeX
@article{Barad2026,
author = {Barad, Priyanka and Samji, Naga Swetha and Raja, FNU and Akce, Mehmet and Malla, Midhun},
title = {Complete Pathological Response to Durvalumab in MSI-H Intrahepatic Cholangiocarcinoma Complicated by Drug-induced Sarcoid-like Reaction: A Case Report},
journal = {Archives of Case Reports: Open Access},
year = {2026},
volume = {03},
number = {02},
pages = {01--05},
doi = {10.33140/acroa.03.02.02}
}
EUVIMED